We also showed that pevonedistat led to activation of the MEK/ERK pathway in ALL cells, and that co-targeting NEDDylation and MEK/ERK resulted in synergistic cell death [4]¬. The gene discussed is MAP2K7; the disease is acute lymphoblastic leukemia.